Cathay Reconciled Depreciation vs Ebitda Analysis

688065 Stock   45.01  0.36  0.79%   
Cathay Biotech financial indicator trend analysis is way more than just evaluating Cathay Biotech prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cathay Biotech is a good investment. Please check the relationship between Cathay Biotech Reconciled Depreciation and its Ebitda accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cathay Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Reconciled Depreciation vs Ebitda

Reconciled Depreciation vs Ebitda Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cathay Biotech Reconciled Depreciation account and Ebitda. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Cathay Biotech's Reconciled Depreciation and Ebitda is 0.93. Overlapping area represents the amount of variation of Reconciled Depreciation that can explain the historical movement of Ebitda in the same time period over historical financial statements of Cathay Biotech, assuming nothing else is changed. The correlation between historical values of Cathay Biotech's Reconciled Depreciation and Ebitda is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Reconciled Depreciation of Cathay Biotech are associated (or correlated) with its Ebitda. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebitda has no effect on the direction of Reconciled Depreciation i.e., Cathay Biotech's Reconciled Depreciation and Ebitda go up and down completely randomly.

Correlation Coefficient

0.93
Relationship DirectionPositive 
Relationship StrengthVery Strong

Reconciled Depreciation

Ebitda

Most indicators from Cathay Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cathay Biotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cathay Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
The current year's Tax Provision is expected to grow to about 56.8 M, whereas Selling General Administrative is forecasted to decline to about 83.2 M.
 2021 2022 2023 2024 (projected)
Interest Expense16.3M20.0M32.2M19.7M
Interest Income213.3M236.8M219.8M156.9M

Cathay Biotech fundamental ratios Correlations

-0.930.640.980.980.380.920.880.930.770.880.91-0.820.670.91-0.740.730.990.740.920.910.830.940.810.82
-0.93-0.41-0.98-0.86-0.05-0.97-0.67-0.9-0.93-0.83-0.920.62-0.54-0.730.72-0.43-0.96-0.64-0.98-0.75-0.96-0.82-0.57-0.58
0.64-0.410.550.720.710.430.770.480.070.480.67-0.750.430.71-0.370.820.610.860.430.750.260.620.840.84
0.98-0.980.550.940.230.950.790.910.850.830.94-0.70.580.81-0.70.591.00.740.960.840.90.860.710.72
0.98-0.860.720.940.540.840.950.910.660.860.87-0.830.710.94-0.710.830.970.760.840.960.720.920.90.91
0.38-0.050.710.230.540.00.760.29-0.230.310.19-0.490.550.6-0.20.890.310.410.00.67-0.190.380.850.84
0.92-0.970.430.950.840.00.640.870.90.80.89-0.710.460.74-0.680.430.940.651.00.690.970.870.530.54
0.88-0.670.770.790.950.760.640.820.440.810.71-0.820.790.95-0.660.950.840.670.640.980.480.850.980.99
0.93-0.90.480.910.910.290.870.820.830.990.83-0.790.840.91-0.920.640.920.50.860.890.810.910.720.73
0.77-0.930.070.850.66-0.230.90.440.830.760.76-0.430.470.56-0.710.160.810.350.910.540.960.680.290.3
0.88-0.830.480.830.860.310.80.810.990.760.78-0.810.90.92-0.970.640.850.420.790.880.740.910.70.71
0.91-0.920.670.940.870.190.890.710.830.760.78-0.70.520.75-0.690.520.930.830.910.80.860.790.660.67
-0.820.62-0.75-0.7-0.83-0.49-0.71-0.82-0.79-0.43-0.81-0.7-0.68-0.930.73-0.8-0.75-0.6-0.68-0.8-0.56-0.95-0.76-0.77
0.67-0.540.430.580.710.550.460.790.840.470.90.52-0.680.86-0.90.70.620.20.460.850.380.720.730.73
0.91-0.730.710.810.940.60.740.950.910.560.920.75-0.930.86-0.830.880.860.590.720.950.60.950.890.9
-0.740.72-0.37-0.7-0.71-0.2-0.68-0.66-0.92-0.71-0.97-0.690.73-0.9-0.83-0.49-0.71-0.26-0.68-0.76-0.67-0.8-0.55-0.56
0.73-0.430.820.590.830.890.430.950.640.160.640.52-0.80.70.88-0.490.660.610.420.880.230.750.970.97
0.99-0.960.611.00.970.310.940.840.920.810.850.93-0.750.620.86-0.710.660.760.940.880.870.890.770.78
0.74-0.640.860.740.760.410.650.670.50.350.420.83-0.60.20.59-0.260.610.760.670.670.550.60.710.71
0.92-0.980.430.960.840.01.00.640.860.910.790.91-0.680.460.72-0.680.420.940.670.690.980.850.530.54
0.91-0.750.750.840.960.670.690.980.890.540.880.8-0.80.850.95-0.760.880.880.670.690.570.850.950.95
0.83-0.960.260.90.72-0.190.970.480.810.960.740.86-0.560.380.6-0.670.230.870.550.980.570.760.360.37
0.94-0.820.620.860.920.380.870.850.910.680.910.79-0.950.720.95-0.80.750.890.60.850.850.760.760.77
0.81-0.570.840.710.90.850.530.980.720.290.70.66-0.760.730.89-0.550.970.770.710.530.950.360.761.0
0.82-0.580.840.720.910.840.540.990.730.30.710.67-0.770.730.9-0.560.970.780.710.540.950.370.771.0
Click cells to compare fundamentals

Cathay Biotech Account Relationship Matchups

Currently Active Assets on Macroaxis

Other Information on Investing in Cathay Stock

Balance Sheet is a snapshot of the financial position of Cathay Biotech at a specified time, usually calculated after every quarter, six months, or one year. Cathay Biotech Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Cathay Biotech and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Cathay currently owns. An asset can also be divided into two categories, current and non-current.